Dr. Giandomenico Turchiano is senior research associate at the Great Ormond Street Hospital, University College of London. His work aims at developing more efficient in-vivo and ex-vivo therapeutic approaches for genetic diseases. He recently created the clinical grade CAST-seq technology for the genotoxicity assessment after designer nuclease treatment of primary cells.